Table 2 Distribution of the study variables in patients with carbapenem resistant and carbapenem susceptible Acinetobacter baumannii infections
Variable | Carbapenem-Resistant (total = 18) | Carbapenem-Susceptible (total = 31) | p |
|---|---|---|---|
n = 18 (%) | n = 31 (%) | ||
Male sex | 8 (44) | 21 (68) | 0.11 |
Agea | 48 (28–63) | 48 (37–58) | 0.94 |
Infection acquired in the ICU | 11 (61) | 13 (42) | 0.20 |
Previous use of any antibiotic b | 14 (88) | 8 (33) | 0.001 |
Previous use of carbapenem b | 10 (63) | 1 (4) | <0.001 |
Non-urinary site of infection | 14 (78) | 21 (68) | 0.45 |
Primary bacteremia | 5 (28) | 12 (39) | |
Pneumonia | 6 (33) | 7 (23) | |
Surgical site infection | 3 (17) | 2 (6) | |
Bacteremia c | 9 (50) | 19 (61) | 0.44 |
Central venous catheter | 16 (89) | 15 (48) | 0.005 |
Mechanical ventilation | 12 (67) | 13 (42) | 0.10 |
Serum creatinine (μmol/L) a | 200 (110 – 290) | 230 (110–460) | 0.39 |
Hemodialysis | 8 (44) | 4 (13) | 0.01 |
Therapy for acute graft rejection | 2 (11) | 10 (32) | 0.10 |
Septic shock | 8 (44) | 7 (23) | 0.11 |
Appropriate empiric therapy for A. baumannii infection | 10 (56) | 19 (61) | 0.69 |